These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 1954046

  • 1. Mechanisms of osteolytic bone destruction.
    Mundy GR.
    Bone; 1991; 12 Suppl 1():S1-6. PubMed ID: 1954046
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular mechanisms of osteolytic bone metastases.
    Guise TA.
    Cancer; 2000 Jun 15; 88(12 Suppl):2892-8. PubMed ID: 10898330
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Bone hyperresorption in bone metastases].
    Clézardin P.
    Presse Med; 2000 Mar 11; 29(9):487-91. PubMed ID: 10745942
    [Abstract] [Full Text] [Related]

  • 10. Breast cancer metastasis to bone: it is not all about PTHrP.
    Bendre M, Gaddy D, Nicholas RW, Suva LJ.
    Clin Orthop Relat Res; 2003 Oct 11; (415 Suppl):S39-45. PubMed ID: 14600591
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Parathyroid hormone-related protein in hypercalcemia associated with hematological malignancy.
    Firkin F, Schneider H, Grill V.
    Leuk Lymphoma; 1998 May 11; 29(5-6):499-506. PubMed ID: 9643563
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The use of clodronate in multiple myeloma.
    Delmas PD.
    Bone; 1991 May 11; 12 Suppl 1():S31-4. PubMed ID: 1835398
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tumor-bone cellular interactions in skeletal metastases.
    Chirgwin JM, Mohammad KS, Guise TA.
    J Musculoskelet Neuronal Interact; 2004 Sep 11; 4(3):308-18. PubMed ID: 15615499
    [Abstract] [Full Text] [Related]

  • 20. Rationale for the use of bisphosphonates in bone metastases.
    Kanis JA, McCloskey EV, Taube T, O'Rourke N.
    Bone; 1991 Sep 11; 12 Suppl 1():S13-8. PubMed ID: 1954047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.